baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Biotie Therapies Corp./ FI0009011571 /

- -	Chg. -	Volume	Bid-	Ask-	High	Low
-USD	-	- Turnover: -	-Bid Size: -	-Ask Size: -	-	-

GlobeNewswire 01-04 Ashvattha Therapeutics Announces the Appointment of Mehdi Paborji as Senior Vice President of Techni...

GlobeNewswire 2021-08-23 Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chie...

GlobeNewswire 2021-08-03 Assembly Bio Announces Key Promotions to Leadership Team

GlobeNewswire 2020-09-17 InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strateg...

GlobeNewswire 2018-06-22 Global CNS Therapeutics Markets, 2016-2018 & 2024: Patent Expiries of Major Drugs Exert Downward Pre...

GlobeNewswire 2018-04-10 Anti-Parkinson's Drugs Markets, 2022

GlobeNewswire 2018-02-06 CNS Therapeutics - Global Strategic Business Report 2017 - Burgeoning Global Aging Populace, Longer ...

GlobeNewswire 2018-01-17 Kessler Topaz Meltzer & Check, LLP - SHAREHOLDER REMINDER: Deadline in Class Action Lawsuit Filed A...

GlobeNewswire 2018-01-06 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acor...

GlobeNewswire 2018-01-04 SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acor...

GlobeNewswire 2018-01-03 Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acorda Therapeutics, Inc. Share...

GlobeNewswire 2017-12-02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda...

GlobeNewswire 2017-11-29 ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Ex...

GlobeNewswire 2017-11-17 Pomerantz Law Firm Announces the Filing of a Class Action against Acorda Therapeutics, Inc. and Cert...

GlobeNewswire 2017-08-24 Global Cell Line Development Services Market, 2027

GlobeNewswire 2016-11-22 Medigene appoints Dr. Thomas Taapken as Chief Financial Officer

GlobeNewswire 2016-09-30 ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST

GlobeNewswire 2016-09-26 ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRAD...

GlobeNewswire 2016-08-26 Biotie: BTT1023 receives Orphan Drug Designation in the United States

GlobeNewswire 2016-08-25 THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.

GlobeNewswire 2016-08-18 BIOTIE THERAPIES CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI

GlobeNewswire 2016-07-28 Biotie Therapies Corp.'s Interim Report for the reporting period January 1 - June 30, 2016

GlobeNewswire 2016-07-19 ARBITRATORS APPOINTED FOR THE REDEMPTION PROCEEDINGS OF BIOTIE'S MINORITY SHARES

GlobeNewswire 2016-06-29 CHANGES IN THE MANAGEMENT TEAM

GlobeNewswire 2016-06-21 Change in Biotie Therapies' Financial Reporting Calendar 2016

Biotie Therapies Corp./ FI0009011571 /

If you wish to receive reply to your feedback, please provide your email address.